Cathie Wood has built her career on holding contrarian views and her Ark Invest firm has been known to go against the grain. As such, 2022’s...
You may know Psychedelic Invest for our trackable index of public companies. You may know us for our constant stream of informative content surrounding...
You may know Psychedelic Invest for our trackable index of public companies. You may know us for our constant stream of informative content surrounding...
Filament Health Corp. (OTCQB: FLHLF | NEO: FH) (FSE: 7QS), a clinical‐stage natural psychedelic drug development company, today announced an agreement...
The Dentinger Lab at the Natural History Museum of Utah has published a provocative new paper in the journal New Phytologist that describes their work...
Disturbed transmission via nicotinic acetylcholine receptors in chick fetuses impairs the hatchlings’ preference for animate objects—similar to what...
MAPS Public Benefit Corporation (“MAPS PBC”), a private company dedicated to the development and commercialization of psychedelic medicines, announced...
The Covid-19 pandemic shifted the economy in many ways. Some industries and practices became nearly obsolete. Other industries have seen exponential growth....
The article MAPS Completes Second Phase 3 MDMA Trial was originally published on Microdose. MAPS PBC Completes Second Phase 3 “MAPP2” Trial of...
The article Predicting Psychedelic Outcomes was originally published on Microdose. One of the hardest parts about taking psychedelics is entering the...